Back

Higher risk of adverse outcomes and need for pacemaker among patients undergoing radiofrequency ablation due to ectopic atrial tachycardia - a Nationwide registry-based Danish study

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Innovations in supraventricular tachycardia management Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Charlotte Middelfart

Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Catheter ablation of atrial arrhythmias by using a multipolar grid-patterned high density mapping catheter in patients with congenital heart disease: a single-center experience
Professor G. Kerst (Stuttgart, DE)
Abstract Slides Video
Presentation thumbnail
Electrophysiological characteristics and catheter ablation of atypical fast-slow atrioventricular nodal reentrant tachycardia using an inferolateral left atrial slow pathway
Associate Professor Y. Kaneko (Maebashi, JP)
Abstract Slides Video
Presentation thumbnail
Utility of open window mapping using high-density mapping approach in accessory pathways ablation
Doctor L. Gonzalez-Melchor (Arrecife, Las Palmas, ES)
Abstract Slides Video
Presentation thumbnail
Acute and long-term success of left atrial anterior line and mitral isthmus line ablation in patients after mitral valve surgery
Doctor C. Lemes (Linz, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Innovations in supraventricular tachycardia management

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Real world data on SVT ablation in Denmark Higher risk of need for reablation in todays patient population a Nationwide registry based Danish study
thumbnail
Congress Presentation
Predicting atrial fibrillation from ECG characteristics
thumbnail
Congress Presentation
Risk of death and thromboembolic events in patients with supraventricular arrhythmias admitted to the emergency department.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources